Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · IEX Real-Time Price · USD
77.76
-0.49 (-0.63%)
Dec 29, 2023, 4:00 PM EST - Market closed
Acadia Healthcare Company Market Cap
Acadia Healthcare Company has a market cap or net worth of $7.17 billion as of December 29, 2023. Its market cap has decreased by -5.63% in one year.
Market Cap
7.17B
Enterprise Value
8.58B
1-Year Change
-5.63%
Ranking
Category
Stock Price
$77.76
Market Cap Chart
Since June 30, 2010, Acadia Healthcare Company's market cap has increased from $69.00M to $7.17B, an increase of 10,292.40%. That is a compound annual growth rate of 41.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 7.17B | -0.63% |
Dec 28, 2023 | 7.22B | -0.55% |
Dec 27, 2023 | 7.26B | -0.14% |
Dec 26, 2023 | 7.27B | 1.19% |
Dec 22, 2023 | 7.18B | 1.53% |
Dec 21, 2023 | 7.07B | 1.36% |
Dec 20, 2023 | 6.98B | -1.12% |
Dec 19, 2023 | 7.06B | 1.04% |
Dec 18, 2023 | 6.98B | 0.40% |
Dec 15, 2023 | 6.96B | -2.77% |
Dec 14, 2023 | 7.15B | -1.75% |
Dec 13, 2023 | 7.28B | 4.02% |
Dec 12, 2023 | 7.00B | 1.27% |
Dec 11, 2023 | 6.91B | 2.32% |
Dec 8, 2023 | 6.76B | 1.78% |
Dec 7, 2023 | 6.64B | 1.17% |
Dec 6, 2023 | 6.56B | -4.12% |
Dec 5, 2023 | 6.84B | -0.72% |
Dec 4, 2023 | 6.89B | 1.21% |
Dec 1, 2023 | 6.81B | 1.19% |
Nov 30, 2023 | 6.73B | 1.49% |
Nov 29, 2023 | 6.63B | -0.11% |
Nov 28, 2023 | 6.64B | -0.68% |
Nov 27, 2023 | 6.68B | -1.47% |
Nov 24, 2023 | 6.78B | 0.81% |
View and export this data all the way back to 2010.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Natera | 7.39B |
Stevanato Group | 7.37B |
Elanco Animal Health | 7.36B |
BridgeBio Pharma | 7.27B |
Ionis Pharmaceuticals | 7.25B |
Ascendis Pharma | 7.20B |
ShockWave Medical | 7.06B |
Intra-Cellular Therapies | 6.93B |